Post by
Nukey on Jan 26, 2021 1:28pm
Emergency Use
Just thinking out loud, but would RVV be able to apply to the FDA for emergency use for Covid as the Bucilllamine has a long history of safely treating things in Asia?
We are in aholdign pattern pending some news, but the company is now well capitalized and new sites appears to me as a good thing.
Just news the all clear or thumbs up from the FDA . Fingers crossed.
Comment by
Towser7 on Jan 26, 2021 7:13pm
Regeneron and Eli Lily releasing positive news on antibody therapies for COVID. By the time phase 3 results come out will anyone care? I understand it will have the ability to help long haulers but the announcement, if we ever get it, is going to have less and less of an impact on stock price.
Comment by
Chrisxd5 on Jan 26, 2021 7:41pm
SIMPLE- They don't work. BUCILLIMINE WILL
Comment by
Towser7 on Jan 26, 2021 8:05pm
I like your optimism! I don't know if I would say the others don't work but we shall see. Certainly going to be interesting...let's hope helpful and profitable too.